156 related articles for article (PubMed ID: 38066528)
1. Dual peptides-modified cationic liposomes for enhanced Lung cancer gene therapy by a gap junction regulating strategy.
Zhao Z; Wang W; Wang G; Huang Z; Zhou L; Lin L; Ou Y; Huang W; Zhang X; Wu C; Tao L; Wang Q
J Nanobiotechnology; 2023 Dec; 21(1):473. PubMed ID: 38066528
[TBL] [Abstract][Full Text] [Related]
2. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of microRNAs that synergize with miR-34a - a basis for combinatorial microRNA therapeutics.
Orellana EA; Li C; Lisevick A; Kasinski AL
Cell Cycle; 2019 Aug; 18(15):1798-1811. PubMed ID: 31258013
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
5. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression.
Shi S; Han L; Deng L; Zhang Y; Shen H; Gong T; Zhang Z; Sun X
J Control Release; 2014 Nov; 194():228-37. PubMed ID: 25220161
[TBL] [Abstract][Full Text] [Related]
6. Gap Junctions Enhance the Antiproliferative Effect of MicroRNA-124-3p in Glioblastoma Cells.
Suzhi Z; Liang T; Yuexia P; Lucy L; Xiaoting H; Yuan Z; Qin W
J Cell Physiol; 2015 Oct; 230(10):2476-88. PubMed ID: 25753094
[TBL] [Abstract][Full Text] [Related]
7. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
Shi Y; Liu C; Liu X; Tang DG; Wang J
PLoS One; 2014; 9(3):e90022. PubMed ID: 24595209
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy.
Hong J; Sim D; Lee BH; Sarangthem V; Park RW
J Nanobiotechnology; 2024 May; 22(1):293. PubMed ID: 38802812
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA delivery by cationic lipoplexes for lung cancer therapy.
Wu Y; Crawford M; Yu B; Mao Y; Nana-Sinkam SP; Lee LJ
Mol Pharm; 2011 Aug; 8(4):1381-9. PubMed ID: 21648427
[TBL] [Abstract][Full Text] [Related]
10. Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer.
Han TY; Hou LS; Li JX; Huan ML; Zhou SY; Zhang BL
Int J Pharm; 2023 Mar; 635():122755. PubMed ID: 36801480
[TBL] [Abstract][Full Text] [Related]
11. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
13. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach.
Salah Z; Abd El Azeem EM; Youssef HF; Gamal-Eldeen AM; Farrag AR; El-Meliegy E; Soliman B; Elhefnawi M
Curr Gene Ther; 2019; 19(5):342-354. PubMed ID: 31701846
[TBL] [Abstract][Full Text] [Related]
14. [Preparation and evaluation of RGD and TAT co-modified paclitaxel loaded liposome].
Gao B; Mu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):769-74. PubMed ID: 25202944
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
16. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
17. Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model.
Hu QL; Jiang QY; Jin X; Shen J; Wang K; Li YB; Xu FJ; Tang GP; Li ZH
Biomaterials; 2013 Mar; 34(9):2265-76. PubMed ID: 23298779
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.
Pang RT; Leung CO; Lee CL; Lam KK; Ye TM; Chiu PC; Yeung WS
BMC Cancer; 2013 Jan; 13():25. PubMed ID: 23327670
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
Wang RH; Cao HM; Tian ZJ; Jin B; Wang Q; Ma H; Wu J
Oncol Rep; 2015 Feb; 33(2):783-91. PubMed ID: 25482610
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Peptide- and Lipid-Based Delivery of miR-34a-5p Mimic into PPC-1 Cells.
Urgard E; Brjalin A; Langel Ü; Pooga M; Rebane A; Annilo T
Nucleic Acid Ther; 2017 Oct; 27(5):295-302. PubMed ID: 28657476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
